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Abstract The goal of this study was to investigate the
effect of a short-term nutritional intervention on gene
expression in adipose tissue from lean and overweight
subjects. Gene expression proﬁles were measured after
consumption of an intervention spread (increased levels of
polyunsaturated fatty acids, conjugated linoleic acid and
medium chain triglycerides) and a control spread (40 g of
fat daily) for 9 days. Adipose tissue gene expression pro-
ﬁles of lean and overweight subjects were distinctly
different, mainly with respect to defense response and
metabolism. The intervention resulted in lower expression
of genes related to energy metabolism in lean subjects,
whereas expression of inﬂammatory genes was down-reg-
ulated and expression of lipid metabolism genes was up-
regulated in the majority of overweight subjects. Individual
responses in overweight subjects were variable and these
correlated better to waist–hip ratio and fat percentage than
BMI.
Keywords Subcutaneous adipose tissue  Microarray 
Polyunsaturated fatty acids (PUFA)  Conjugated
linoleic acid (CLA)  Medium chain triglycerides
Introduction
Adipose tissue not only functions as a fat storage organ, it
also has an important metabolic and endocrine function.
Adipose tissue plays a role in insulin sensitivity and
inﬂammatory status, e.g., through release of fatty acids and
adipokines [1, 27]. In obesity, adipose tissue mass is
increased and as a result, endocrine and metabolic func-
tions of adipose tissue are affected. Moreover, obesity is
associated with systemic inﬂammation due to macrophage
inﬁltration in adipose tissue. Complications of obesity
include insulin resistance, cardiovascular disease and
metabolic syndrome [1, 38, 39].
It has been shown that energy restriction, changes in
dietary macronutrient composition and weight loss result in
gene expression changes in adipose tissue from overweight
or obese subjects [6, 22, 35]. The goal of this study was to
investigate the effects of a short-term nutritional inter-
vention on gene expression in adipose tissue and to
investigate whether the gene expression response differs
between lean and overweight subjects. Earlier, we showed
that dietary effects can be monitored by gene expression
proﬁling in white blood cells [32].
The nutritional intervention consisted of a spread with
increased levels of medium chain triglycerides, short-chain
polyunsaturated fatty acids (PUFA: C18:2 and C18:3) and
conjugated linoleic acid (CLA: C18:2) (further referred to
as intervention spread). This composition was chosen to
elicit an effect on food intake and satiety. Medium chain
triglycerides, PUFA and CLA are reported to have satiating
power [13, 18, 29]. The two spreads did not differ in their
effect on satiety (described in detail elsewhere: Pasman
et al., in preparation). To a large extent, it is unknown how
the fatty acids can inﬂuence food intake, energy expendi-
ture and eventually body mass [17]. Analysis of adipose
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role in fat and energy metabolism in response to nutritional
interventions and because of its role in inﬂammation.
Furthermore, PUFA have been reported to inﬂuence adi-
pose tissue function [5, 21] and CLA can play a role in
reduction of adipose tissue mass [3, 37, 40].
We found that in adipose tissue fatty acid transporter
gene expression was slightly higher in lean subjects and
slightly lower in overweight subjects in response to the
intervention spread compared to the control spread. Also,
fatty acid uptake showed a tendency to change in response
to the intervention (details in Pasman et al., in preparation).
Here we study in greater detail the response of adipose
tissue to the different fatty acid intake by whole genome
gene expression proﬁling of subcutaneous adipose tissue
biopsies taken from the subjects after consumption of the
intervention or control spread with an equal amount of fat
for 9 days.
Effects of the short-term nutritional intervention were
studied both in overweight and lean subjects, by focusing
on enriched functional groups of genes and putting these in
the context of the intervention, thereby aiming to shed a
light on the potential mechanisms of action of the fatty
acids.
Subjects and methods
Study design and subjects
The study was conducted at TNO Quality of Life, where
subjects were recruited from a pool of volunteers. Each
subject was informed about the study orally and in writing
before they signed the informed consent forms. Subjects
met the inclusion criteria: (1) healthy male subjects (lean:
BMI between 18 and 25 kg/m
2 or overweight/obese: BMI
between 27.5 and 35 kg/m
2), (2) normal Dutch eating
pattern and used to consuming breakfast, (3) non-restrained
eaters according to the Dutch Eating Behavior Question-
naire (lean: \2.5 and overweight/obese: \3.25) [33, 34].
Subjects with a disorder, using medication or having a
history of medical or surgical events that may have affected
study outcomes were excluded.
A total of 25 subjects (all of Dutch ancestry) were
eligible of which 20 subjects were randomly selected as
well as four reserves. Ten lean (BMI mean ± SD 21.2 ±
1.5 kg/m
2, age range 19–41 years) and ten overweight men
(BMI 29.7 ± 1.9 kg/m
2, age range 21–58 years) started
and completed the study. Body fat percentage was
12.2 ± 4.2% in the lean sub-group compared to 27.8 ±
3.7% in the overweight sub-group. Waist circumference
was 79 ± 6 cm in the lean sub-group compared to
102 ± 8 cm in the overweight sub-group and waist–hip
ratio (WHR) was 0.86 ± 0.05 in the lean sub-group com-
pared to 0.96 ± 0.07 in the overweight subgroup.
The study was approved by the Medical Ethics Com-
mittee of the University Medical Centre of Utrecht (20
September 2005) and conducted according to the ICH
Guideline for Good Clinical Practice in October–Novem-
ber 2005.
The study was designed as a randomized cross-over,
placebo-controlled, double blind study. Each subject
received two treatments. The treatment period lasted nine
days and the wash-out period was 2 weeks. The two
treatments consisted of a spread containing fatty acids
known for their satiating effect [increased levels of med-
ium chain triglycerides, short-chain polyunsaturated fatty
acids (PUFA: C18:2 and C18:3) and conjugated linoleic
acid (CLA: C18:2) (further referred to as intervention
spread)] and a control spread containing fatty acids nor-
mally eaten with breakfast. The exact composition of the
spreads is presented in Table 1. Blends with the fatty acids
of interest were mixed by Lipid Nutrition (Wormerveer,
The Netherlands). Romi Smil (Heerenveen, The Nether-
lands) prepared the spreads. The subjects used the spread
with breakfast and lunch; 26 grams in the morning, and
26 g in the afternoon (in total 52 g of spread daily, con-
taining 40 g of fat). The spreads replaced the spread
normally consumed in the diet. The amount of fat supplied
in the spread was similar in both interventions and energy
intake was kept constant, resulting in a difference in fatty
acid composition intake only.
No carry-over effect of treatments was found for
bodyweight (data not shown).
Adipose tissue biopsies
Two fat biopsies were taken from each subject, one after
consumption of the placebo spread for 9 days and one after
consumption of the intervention spread for 9 days. Biop-
sies were taken in the evening and time of sampling was
Table 1 The composition of the spreads
Intervention
spread (%)
Control
spread (%)
Lauric acid (MCT, C12:0) (and C14:0) 17.2 0
Palmitic acid (C16:0) 17.9 17.5
Stearic acid (C18:0) 3 10
Oleic acid (C18:1) 4.5 40
Conjugated linoleic acid (C18:2) 12.4 0
Linoleic acid (C18:2) 40.3 30
Pinolenic acid (C18:3) 2.5 0
Other fatty acids 2.2 2.5
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123kept constant as much as possible for the two treatments.
Subcutaneous adipose tissue was obtained from the
abdominal region by needle aspiration under local anes-
thesia using 29 50 ml 8.4% NaHCO3, 0.05% lidocaine and
1.0 mg/ml epinephrine (according to Kolaczynski et al.
[16]). Part of the fat suspension was immediately frozen in
liquid nitrogen and stored at -80C for RNA isolation.
RNA isolation, labeling and hybridization
RNA was isolated by homogenizing the adipose tissue
biopsies in Trizol (Life Technologies S.A., Merelbeke,
Belgium). After chloroform extraction the RNA isolation
was continued using NucleoSpin RNA II kit (Bioke ´, Lei-
den). The protocol included a DNase digestion step.
The isolated RNA samples were processed according to
Affymetrix protocols by Scienion Ag (Berlin, Germany). In
brief, RNA quality and integrity were veriﬁed using the
RNA 6000 Nano assay on the Agilent 2100 Bioanalyzer
(Agilent Technologies), resulting in RNA samples from ten
lean and eight overweight subjects to be included in the
microarray analysis (RNA samples from two overweight
subjects did not pass the RNA quality control).
Next, 1.5 lg of high-quality total RNA was used with
the Affymetrix Eukaryotic One-Cycle Target Labeling and
Control reagents to generate Biotin-labeled antisense
cRNA. The labeled cRNA was further used for the
hybridization to the NuGO Affymetrix Human Genechip
NuGO_Hs1a520180 (custom designed by the European
Nutrigenomics Organization NuGO, consisting of 23,941
probesets including 71 control probesets, for details see
http://blog.bigcat.unimaas.nl/*martijn/NuGO/). After an
automated process of washing and staining, absolute values
of expression were calculated from the scanned array using
the Affymetrix GCOS software.
Data analysis
Quality control of microarray data was performed using
BioConductor packages (a.o. simpleaffy and affyplm,
through the NuGO MadMax pipeline: https://madmax.
bioinformatics.nl). One microarray did not pass quality
control criteria due to high background values and low
percentage of present calls. Therefore, microarray data for
nine lean and eight overweight subjects were included in
data analysis.
Raw signal intensities (from CEL ﬁles) were normalized
using the GCRMA algorithm (gc-rma slow). Probesets
were ﬁltered on at least one present call and at least one
expression value above 5 (resulting in a set of 15,762
probesets). Expression data were log-transformed (base 2).
The cross-over design of the study ensured measurement of
gene expression proﬁles in adipose tissue of each subject
after consumption of the placebo spread and after con-
sumption of the intervention spread, allowing for analysis
of gene expression changes in response to intervention
within each subject [calculated as 2log ratio (intervention
vs placebo)].
First, effects of BMI (lean sub-group or overweight sub-
group), treatment (intervention spread or control spread) as
well as the interaction component BMI 9 Intervention was
tested using two-way ANOVA in SAS (SAS Institute Inc.,
Cary, USA). The null hypotheses (no difference) were
rejected at the level of 0.01 of probability. When testing
15,762 probesets with these conditions, 158 probesets are
expected to be called signiﬁcant.
Second, a paired t test for treatment effect in the lean
and in the overweight subgroup was performed in BRB
ArrayTools (software for microarray data analysis devel-
oped by Dr. Richard Simon and Amy Peng Lam,
http://linus.nci.nih.gov/BRB-ArrayTools.html), using mul-
tiple testing correction by estimation of false discovery rate
(FDR). Threshold for signiﬁcance was set by taking into
account P value (\0.01) as well as estimated FDR (\20%).
Finally, in case of responders and non-responders within a
sub-group, differentially expressed genes were selected
based on showing a consistent response in the majority of
the subjects (deﬁned as C25% expression change up in
more than 50% of the subjects or C25% expression change
down in more than 50% of the subjects).
Subsets of differentially expressed genes were analyzed
further in GenMAPP to ﬁnd functional groups of genes
(based on Gene Ontology) that were overrepresented in
the subsets [7]. Other tools used for data analysis include
Gene Set Enrichment Analysis [31] and T-proﬁler [2]
for enrichment analysis of functional groups of genes.
The tissue-speciﬁc gene sets were derived from SymAtlas
(http://symatlas.gnf.org/SymAtlas/)[ 30] and from Lyons
et al. [20]. Cluster and treeview (http://rana.lbl.gov/
EisenSoftware.htm,[ 8]) were used for generation of clus-
ter trees, using average linkage clustering and uncentered
correlation as similarity metric. A biological network was
generated in MetaCore version 4.3 (GeneGo Inc., St
Joseph, MI, USA). MetaCore
TM is based on a proprietary
manually curated database of human protein–protein, pro-
tein–DNA and protein compound interactions, metabolic
and signaling pathways and the effects of bioactive mole-
cules in gene expression. Only curated interactions were
used.
Data from the placebo intervention were used for
comparison of gene expression levels in adipose tissue
from lean and overweight subjects.
The gene expression data are available through Array-
Express, a public repository for microarray data (http://
www.ebi.ac.uk/arrayexpress/, accession numer E-TABM-
377).
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123Results
Subcutaneous adipose tissue gene expression proﬁles of
lean and overweight subjects were distinctly different
(3,069 probesets selected with P\0.01 for BMI-effect;
Fig. 1). An overview of enriched functional groups of
genes (based on Gene Ontology) in this set of 3,069
probesets is shown in Table 2. Genes involved in energy
metabolism were expressed at a higher level in adipose
tissue from lean subjects (functional groups ‘generation of
precursor metabolites and energy’, ‘lipid metabolism’,
‘glucose metabolism’). Furthermore, genes encoding
mitochondrial proteins were expressed at a higher level in
adipose tissue from lean subjects than in adipose tissue
from overweight subjects.
On the other hand, genes involved in defense response,
intracellular signaling and cell adhesion were expressed at
higher levels in adipose tissue from overweight subjects
than in adipose tissue from lean subjects. Within these
groups of genes, gene expression of speciﬁc macrophage
markers [e.g., CD14, CD163 and macrophage scavenger
receptor 1 (MSR1)] was signiﬁcantly higher in adipose
tissue of overweight subjects (P\0.001 for BMI-effect in
two-way ANOVA), pointing towards presence of macro-
phages or inﬂammatory cells in the adipose tissue biopsies
from overweight subjects. This is further illustrated in
supplementary Fig. 1, which clearly shows higher expres-
sion of genes speciﬁc for CD14-positive monocytes in
adipose tissue from seven overweight subjects than in
adipose tissue from lean subjects. Enrichment analysis of
tissue-speciﬁc gene sets, by comparing the lean sub-group
to overweight sub-group (GSEA) and by analyzing over-
weight subjects individually (T-proﬁler), showed that this
set of genes speciﬁc for CD14-positive monocytes was
signiﬁcantly enriched in the adipose tissue from over-
weight subjects compared to lean subjects and that this
gene set was among the two most enriched gene sets in
seven out of the eight overweight subjects. Other inﬂam-
matory markers that were expressed at higher level in
adipose tissue from overweight subjects included leptin,
complement factor D (CFD), interleukin receptor 6 (IL6R),
interleukin receptor 10 alpha (IL10RA), interleukin 1
receptor antagonist (IL1RN) and a number of interleukins
(IL15, IL17D, IL18) (data not shown).
Consumption of the intervention spread resulted in a
differential gene expression response in adipose tissue from
lean and overweight subjects, as indicated by the BMI-
intervention interaction effect (706 probesets selected with
P\0.01 for BMI 9 intervention interaction effect;
Fig. 1). When plotting the expression changes (intervention
spread versus control spread) of this set of 706 genes in the
lean and overweight subjects (Fig. 2), it can be seen that
the expression changes are more pronounced (larger fold
changes) in the lean subjects than in the overweight sub-
jects. In addition, statistical analysis of treatment effects in
the lean and overweight sub-group individually resulted in
no probesets signiﬁcantly differentially expressed due to
the intervention in overweight subjects compared to 813
differentially expressed probesets due to the intervention in
lean subjects.
Enrichment analysis of the set of differentially expres-
sed genes in lean subjects indicated that in lean subjects
consumption of the intervention spread led to down-regu-
lation of genes involved in functional groups indicated as
‘mitochondrion’, ‘generation of precursor metabolites and
energy’, ‘lipid metabolism’, ‘carbohydrate metabolism’
(Table 3), together pointing towards a general effect on
energy metabolism. These selected ‘energy metabolism’
genes showed considerable variation in their response
among the overweight subjects (supplementary Fig. 2).
The results indicate that in the overweight subjects the
response to the intervention is less strong and more vari-
able than in the lean subjects. We further explored the
possibility that a selection of the overweight subjects did
show a consistent gene expression response for a number of
genes or processes. Therefore, genes were selected based
on showing a consistent response in the majority of the
subjects (deﬁned as C25% expression change up in more
than 50% of the subjects or C25% expression change down
in more than 50% of the subjects). In total, 501 probesets
fulﬁlled these criteria. Enriched functional groups in this
set of genes were ‘lipid metabolism’, ‘response to stress’,
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Fig. 1 Results of 2-way ANOVA investigating effect of BMI [lean
(n = 9) or overweight (n = 8) group], intervention (intervention
spread or placebo) and BMI 9 intervention interaction. Threshold for
signiﬁcance was set at P\0.01. Testing 15,762 probesets with P
value threshold of 0.01 would result in 158 probesets detected as
signiﬁcant by chance
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123‘extracellular matrix’, ‘apoptosis’ and ‘cell adhesion’.
Clustering of the genes in these functional groups (Fig. 3)
illustrate variation in response among the overweight
subjects, but also show that six of the overweight subjects
show a similar response for most functional groups,
whereas two other respond differently. Interestingly,
expression of a number of the lipid metabolism and
inﬂammatory genes (response to stress) in the clusters was
Table 2 Enriched functional groups (based on Gene Ontology) in total set of differentially expressed genes in lean versus overweight subjects
(3,069 probesets), in genes expressed at high levels in lean than in overweight (1,325 probesets) and in genes expressed at higher levels in lean
than overweight (1,744 probesets)
GO
group
Functional group of genes Number of genes
measured
All genes Higher in lean Higher in overweight
Percent
changed
Z
score
a
Percent
changed
Z
score
Percent
changed
Z
score
CC Mitochondrion 522 38.5 14.4 34.3 25.7
BP Generation of precursor metabolites and energy 508 29.5 8.6 21.5 13.6
BP Oxidative phosphorylation 77 36.4 4.9 31.2 8.6
BP Lipid metabolism 503 27.6 7.3 17.9 10.2
BP Carbohydrate metabolism 392 25.5 5.3 12.5 4.7 13.0 2.6
BP Glucose metabolism 77 28.6 3.0 22.1 5.4
BP Mitochondrial transport 17 41.2 2.9 41.2 5.7
BP Cell adhesion 502 19.1 2.0 13.3 3.3
BP Cell-matrix adhesion 60 28.3 2.6 25.0 4.2
BP Defense response 723 24.2 6.3 21.5 11.8
BP Inﬂammatory response 183 26.2 3.8 24.6 7.2
BP Response to stress 829 20.6 3.8 17.0 8.0
BP Intracellular signaling cascade 930 19.1 2.8 13.8 5.0
BP I-kappaB kinase/NF-kappaB cascade 98 28.6 3.4 22.4 4.5
MF Scavenger receptor activity 28 32.1 2.4 32.1 4.2
Enrichment analysis was performed in GenMAPP, by comparing the three selected sets of genes (all genes differentially expressed in lean versus
overweight subjects, genes expressed at higher levels in lean than in overweight subjects and genes expressed at higher levels in overweight than
in lean) to all genes on the microarray. Data from the placebo intervention were used for comparison of gene expression levels in adipose tissue
from lean and overweight subjects
GO Gene Ontology groups, CC cellular component, BP biological process, MF molecular function
a All Z scores in table: P\0.05 (PermuteP)
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Fig. 2 Overview of expression
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control spread) of 706 probesets
(P\0.01 for BMI 9 treatment
effect) in nine lean (L left side)
and eight overweight (O right
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123signiﬁcantly different in overweight compared to lean
subjects (BMI-effect) and changed in response to con-
sumption of the intervention spread in direction of
expression levels in lean subjects (genes marked with
asterisk in Fig. 3).
Finally, individual response in overweight subjects was
studied on level of functional groups of genes, using
T-proﬁler [2], resulting in an enrichment score for func-
tional groups in individual subjects based on gene
expression changes in response to the intervention. A
number of functional gene groups showed considerable
variation in response among the overweight subjects, with
up-regulation in one or more subjects and down-regulation
in one or more other subjects. These functional gene groups
include ‘mitochondrion’, ‘cell adhesion’ and ‘extracellular
matrix’, ‘immune response’ and ‘inﬂammatory response’.
Interestingly, the individual response with regard to these
functional groups correlated signiﬁcantly to obesity phe-
notype markers WHR or fat percentage (Fig. 4). WHR
correlated negatively with response of mitochondrial genes
and positively with response of genes involved in cell
adhesion. In addition, fat percentage correlated positively
with response of inﬂammatory genes.
Discussion
To our knowledge, this study is one of the ﬁrst to per-
form large-scale gene expression analysis in human
adipose tissue biopsies in response to a short-term
nutritional intervention, in both lean and overweight
subjects. The study is exploratory in nature and describes
the results on a pathway or functional group level with
interpretation in relation to the intervention and literature
data.
Our study data indicated that a considerable part of the
differences in gene expression proﬁles could be attributed
to the difference in BMI between the two sub-groups.
Expression of inﬂammation-related genes was signiﬁcantly
higher in subcutaneous adipose tissue biopsies from over-
weight subjects than those from lean subjects. Speciﬁcally,
markers speciﬁc for monocytes in blood were signiﬁcantly
higher expressed in the adipose tissue from overweight
subjects, as was shown by different enrichment analysis
approaches. As tissue macrophages originate from mono-
cytes in blood that migrate into tissue, this ﬁnding is
consistent with increased macrophage content of adipose
tissue from overweight subjects, as previously described by
others [38]. In addition to macrophage markers, also
expression of speciﬁc adipokines was different between
lean and overweight subjects. Consistent with other reports
[14, 23], expression of leptin was higher and expression of
adiponectin was lower (although not signiﬁcantly) in adi-
pose tissue from overweight subjects than in adipose tissue
from lean subjects.
Expression of metabolism-related genes and genes
encoding mitochondrial proteins was higher in subcutane-
ous adipose tissue from lean subjects than in adipose tissue
from overweight subjects. A recent study of transcription
proﬁles in adipose tissue from monozygotic twins discor-
dant for BMI also reported lower expression of genes
related to energy metabolism in obese subjects [26]. In
addition, they report a reduction in mitochondrial DNA in
adipose tissue from obese subjects. Overall, this indicates a
Table 3 Enriched functional groups (based on Gene Ontology) in set of differentially expressed genes (813 probesets) and in sub-set of down-
regulated genes (509 probesets) in sub-group of lean subjects in response to treatment
GO group Functional group of genes Number of
genes measured
All Down-regulated
Percent changed Z score Percent changed Z score
CC Mitochondrion 522 6.5 3.1 5.7 4.1
BP Generation of precursor metabolites and energy 508 6.9 3.5 5.5 3.7
BP Lipid metabolism 503 6.2 2.7 5.8 4.0
BP Carbohydrate metabolism 391 6.1 2.3 5.9 3.7
BP Glucose metabolism 77 10.4 2.9 10.4 4.0
BP Mitochondrial transport 17 23.5 4.2 23.5 5.1
BP Regulation of cell cycle 367 6.27 2.36 4.9 2.4
BP Complement activation\, classical pathway 22 13.6 3.0
BP Oxygen and reactive oxygen species metabolism 65 7.7 2.4
Enrichment analysis was performed in GenMAPP, by comparing the two selected sets of genes (all genes differentially expressed in lean subjects
in response to intervention and sub-set of down-regulated genes in lean subjects in response to treatment) to all genes on the microarray
GO Gene Ontology groups, CC cellular component, BP biological process
a All Z scores in table: P\0.05 (PermuteP)
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123possible difference in mitochondrial content or mitochon-
drial activity in adipose tissue from lean subjects and
overweight subjects. However, it can not be excluded that
the increased mitochondrial activity actually reﬂects a dif-
ference in cell number in the adipose tissue biopsies, as
increased adipose tissue mass can be due to increased adi-
pocyte cell size as well as increased number of adipocytes.
The dietary intervention consisted of replacement of
oleic acid and stearic acid in the placebo spread by short-
chain polyunsaturated fatty acids (PUFA: C18:2 and
C18:3), conjugated linoleic acid (CLA: C18:2) and med-
ium chain triglycerides (C12:0) in the intervention spread.
Thus, the gene expression differences can be related to
differences in intake of all these fatty acids and should be
interpreted in that context.
Both CLA and PUFA (speciﬁcally n-3 PUFA) can exert
anti-inﬂammatory effects [4, 24]. In the majority of over-
weight subjects, dietary intervention resulted in down-
regulation of expression of a number of inﬂammation-
related genes (in enriched category ‘response to stress’)
Fig. 3 Cluster maps of genes in
biological processes enriched in
set of genes with consistent
expression change ( C25%) in
the majority of overweight
subjects. Expression changes
(2log ratio) of intervention
spread versus placebo spread in
eight overweight subjects were
submitted to gene and sample
clustering (using average
linkage clustering and
uncentered correlation as
similarity metric). Red color
indicates up-regulation of
expression in response to
intervention spread compared to
placebo spread. Green color
indicates down-regulation of
expression in response to
intervention spread compared to
placebo spread. Asterisks are
signiﬁcantly different
expression in overweight
compared to lean subjects
(BMI-effect) and expression
changed in response to the
intervention spread in direction
of expression levels in lean
subjects (colour in online)
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123that were expressed at signiﬁcantly higher level in adipose
tissue from overweight subjects than in adipose tissue from
lean subjects. This anti-inﬂammatory effect of the inter-
vention was, e.g., seen for macrophage inﬂammatory
protein 2 alpha (CXCL2), macrophage receptor MARCO
(MARCO) and interleukin-1 receptor antagonist (IL1RN).
In adipose tissue from lean subjects, the anti-inﬂammatory
effect of the dietary intervention was restricted to down-
regulation of genes involved in complement activation
pathway (three subunits of complement C1q) and genes
involved in reactive oxygen species metabolism.
Additionally, in adipose tissue from lean subjects the
dietary intervention resulted in a down-regulation of genes
involved in energy metabolism-related processes (genera-
tion of precursor metabolites and energy, lipid metabolism,
carbohydrate metabolism). Biological network analysis
revealed that a number of the differentially expressed
energy metabolism genes are targets of HNF4-alpha in
liver and/or pancreas [25, 37]. Thus, possibly the expres-
sion of genes related to energy metabolism could have been
regulated through transcription factor HNF4-alpha (Fig. 5).
PUFA can bind to and repress activity of HNF4-alpha [11,
28, 37]. This implicates that, in addition to liver, HNF4-
alpha could be an important regulator of gene expression
and energy metabolism in adipose tissue, at least in lean
subjects.
In the majority of overweight subjects, dietary inter-
vention affected expression of genes involved in lipid
metabolism, resulting mostly in up-regulation of expression
(Fig. 3). Expression of lipid metabolism genes was lower in
adipose tissue from overweight subjects than in adipose
tissue from lean subjects, therefore increased expression of
lipid metabolism genes might be a beneﬁcial effect of the
intervention in overweight subjects. Moreover, increased
energy expenditure as a result of up-regulation of lipid
metabolism could be one of the mechanisms through which
CLA decreases adipose tissue mass [4, 24, 37] and it could
play a role in the proposed increase of energy expenditure
by medium chain triglycerides [29]. Additional effects of
the dietary intervention in the majority of overweight sub-
jects included effects on genes involved in apoptosis and
genes involved in cell adhesion and extracellular matrix.
Effects on these processes are consistent with recently
described effects of CLA and PUFA [9, 12, 37].
In overweight subjects the response to the dietary
intervention was not as strong as in the lean subjects and
moreover, the response among the overweight subjects was
variable. The consistent response in a selection of over-
weight subjects was not related to treatment order.
Possibly, adipose tissue in overweight subjects is not as
ﬂexible and responsive to dietary intervention as adipose
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Fig. 4 Scatter plots of obesity phenotype parameters (waist–hip ratio
WHR or fat percentage) and scores (t value) for enrichment of
functional processes (based on Gene Ontology) that were affected by
dietary intervention. a Score for enrichment of genes encoding
mitochondrial proteins for each overweight subject plotted against
WHR; b Score for enrichment of cell adhesion genes plotted against
WHR; c Score for enrichment of inﬂammatory response genes for
each overweight subject plotted against fat percentage
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123tissue in lean subjects. Also, the intervention effect might
have been diluted due to increased adipose tissue mass in
overweight subjects compared to the lean subjects, there-
fore resulting in less pronounced expression changes.
Lastly, genotype and polymorphisms can not be exluded as
a factor in the variation in response.
The overweight subjects were selected based on BMI, an
obesity marker that does not take fully into account adipose
tissue distribution in the body. In contrast, WHR and waist
circumference are more speciﬁc markers for body fat dis-
tribution and presence of central or upper-body obesity [15,
19]. Interestingly, the individual response of the over-
weight subjects to the intervention correlated to the obesity
phenotype markers WHR and fat percentage. For example,
expression of mitochondrial genes was up-regulated in
response to dietary intervention in the overweight subject
with the lowest WHR and down-regulated in response to
intervention in the overweight subject with the highest
WHR. Interestingly, these two subjects have a similar BMI.
Overall, these results show that the subjects, classiﬁed as
overweight on the basis of their BMI, are heterogeneous in
their response to dietary intervention and that this response
is associated with obesity phenotype markers WHR and fat
percentage, suggesting a link between body fat distribution
and response to nutritional intervention.
The fat biopsies analyzed were subcutaneous biopsies,
taken from the abdomen. Abdominal fat, mostly visceral
abdominal fat, is often linked to complications and disease
progression [36]. However, some studies report a role for
subcutaneous abdominal tissue in obesity related diseases
[10]. The ﬁnding that subcutaneous adipose tissue responds
to nutritional intervention is encouraging for further
research, as this is the only easily accessible source of
adipose tissue from humans. Thus, whole genome expres-
sion proﬁling in adipose tissue may help to identify
relevant mechanisms and targets of nutritional intervention
in obesity prevention or treatment.
In summary, response to the dietary intervention was
different in lean and overweight subjects. Increased
short-chain polyunsaturated fatty acids (PUFA: C18:2
and C18:3), conjugated linoleic acid (CLA: C18:2) and
medium chain triglycerides (C12:0) consumption resulted
in lower expression of genes related to energy metabo-
lism in lean subjects, whereas in the majority of
Fig. 5 Network of direct interactions between transcription factors
HNF4alpha, SREBP1 and PPARA and genes involved in energy
metabolism that were differentially expressed in lean subjects in
response to intervention spread compared to control spread. Arrow
pointing down indicates down-regulation of expression in response to
intervention spread compared to control spread, arrow pointing up
indicates up-regulation of expression in response to intervention
spread compared to control spread. Lines between symbols indicate
connections described in literature. This ﬁgure was made using
MetaCore
TM (v4.3) from GeneGo Inc.LIPA Lipase A, GPD1 glycerol-
3-phosphate dehydrogenase 1, UCP2 mitochondrial uncoupling
protein 2, DHCR7 7-dehydrocholesterol reductase; MVD diphospho-
mevalonate decarboxylase; ACACA acetyl-coA carboxylase 1; ACLY
ATP citrate lyase; CISY citrate synthase; NDUFA3 NADH dehydro-
genase (ubiquinone) 1 alpha subcomplex, 3; AD014(TOM7)
translocase of outer mitochondrial membrane 7 homolog (yeast);
UGTREL7 UDP-glucuronic acid/UDP-N-acetylgalactosamine trans-
porter; THTPA thiamine-triphosphatase; SUOX Sulﬁte oxidase,
mitochondrial precursor; PI4Kbeta: Phosphatidylinositol 4-kinase
beta; 101F6: Cytochrome b561 domain-containing protein 2;
TXNDC14: thioredoxin domain containing 14; PKM2 Pyruvate kinase
2/3; C14orf1: Probable ergosterol biosynthetic protein 28; PINK1
Serine/threonine-protein kinase PINK1, mitochondrial precursor;
IFRD2 Interferon-related developmental regulator 2; HYAL3 Hyal-
uronidase-3 precursor; KARS Lysyl-tRNA synthetase; SLC35A2 UDP-
galactose translocator
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123overweight subjects expression of inﬂammatory genes
was down-regulated and expression of lipid metabolism
genes was up-regulated. Individual responses in over-
weight subjects were variable and these correlated better
to obesity phenotype markers WHR and fat percentage
than BMI.
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